Bellevue, WA, United States of America

John M Delaney

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Wayne, NJ (US) (1981)
  • Newbury Park, CA (US) (2000 - 2001)
  • Bellevue, WA (US) (2015 - 2019)

Company Filing History:


Years Active: 1981-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: John M Delaney: Innovator in CD27L Antigen Binding Proteins

Introduction

John M Delaney is a notable inventor based in Bellevue, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of CD27L antigen binding proteins. With a total of 6 patents to his name, Delaney's work has the potential to impact the diagnosis and treatment of various diseases.

Latest Patents

Delaney's latest patents focus on CD27L antigen binding proteins. These inventions include antibodies, polynucleotides encoding said CD27L antigen binding proteins, antibody drug conjugate compositions, and methods for diagnosing and treating diseases associated with CD27L expression. His innovative approach in this area showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, John M Delaney has worked with prominent companies, including Amgen Inc. His experience in the biotechnology sector has allowed him to develop groundbreaking technologies that contribute to healthcare advancements.

Collaborations

Delaney has collaborated with notable individuals in his field, including Chadwick Terence King and Ella Magal. These partnerships have likely enriched his research and development efforts.

Conclusion

John M Delaney is a distinguished inventor whose work on CD27L antigen binding proteins exemplifies innovation in biotechnology. His contributions continue to pave the way for advancements in medical treatments and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…